tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

Medexus Pharmaceuticals Accepts Metoject® Ruling
Company AnnouncementsMedexus Pharmaceuticals Accepts Metoject® Ruling
7d ago
Medexus Pharmaceuticals Shines at Investor Conference
PremiumCompany Announcements
Medexus Pharmaceuticals Shines at Investor Conference
1M ago
Medexus’s Hemophilia B Drug Now Pediatric-Approved
PremiumCompany Announcements
Medexus’s Hemophilia B Drug Now Pediatric-Approved
1M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
PremiumPress Releases
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
8M ago
Is MDP a Buy, Before Earnings?
PremiumPre-EarningsIs MDP a Buy, Before Earnings?
9M ago
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
11M ago
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
PremiumPress Releases
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
1y ago
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
PremiumPress Releases
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
1y ago
Medexus Announces New License Deal for Topical Terbinafine
PremiumPress Releases
Medexus Announces New License Deal for Topical Terbinafine
1y ago
Medexus Announces US$58.5 million in New Credit Facilities
PremiumPress Releases
Medexus Announces US$58.5 million in New Credit Facilities
1y ago
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
PremiumPress Releases
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
1y ago
Medexus Welcomes Two New Board Members
PremiumPress ReleasesMedexus Welcomes Two New Board Members
1y ago
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
PremiumPress Releases
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
1y ago
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
PremiumPress Releases
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
1y ago
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
PremiumPress ReleasesMedexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >